Abstract
Implantation was perhaps the first therapeutic tool in regenerative medicine. Since the first tissue implants were launched, the economical meaning of treating degenerative disease, and the influence in health care costs for the elderly population, has become more apparent (1). It is also clear that tissue implant use fails, as the majority of implants do not integrate within the host tissue, die, or are no longer available after a period of time. Although implants may be mechanically durable and made of biologically inert materials, implants and their lack of biocompatibility accelerate the need for innovative means of regenerating loss or decayed tissue (2, 3). Alternatively, in the arena of the elderly, neurological and cardiac diseases will have major roles in the overall costs of health and consequent pharmaceutical, device, hospital, and clinical practices for the next 25 yr. The great therapeutic potential of stem cells in treating degenerative diseases can be rationalized, as cell therapy and tissue engineering may be considered the most relevant window of opportunity in health-related business for the dawn of the 21st century (4). Will cell therapy be a tailor-made process? Will autologous cell transplantation become a standard medical procedure? Will off-the-shelf cell treatments soon be packaged, prescribed, and routinely used in the hospital environment?
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ratner, B. D., Hoffman, A. S., Schoen, F. J., and Lemmons, J. E., eds. (1996) Applications of materials in medicine and dentistry. In Biomaterials Science: An Introduction to Materials in Medicine. Academic Press, San Diego, pp. 283–388.
Spector, M. (1992) Biomaterials failure. Orthop. Clin. North Am. 23, 211–217.
Anderson, J. M. (1994) Inflammation and the foreign body response. Prob. Gen. Surg. 11, 101–107.
(2005) Bioengineered tissues: the science, the technology, and the industry. Orthodontics Craniofacial Res. 8, 134.
Vats, A., Bielby, R. C., Tolley, N. S., et al. ( 2005) Stem cells. Lancet 366, 592–602.
Borlongan, C. V., Fournier, C., Stahl, C. E., et al. ( 2006) Gene therapy, cell transplantation and stroke. Front Biosci. 11, 1090–1101.
Grill, R., Gage, F. H., Murai, K., et al. ( 1997) Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. 17, 5560–5572.
Henning, R. J., Abu-Ali, H., Balis, J. U., et al. ( 2004) Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 13, 729–739.
Martina, V., Jordan, C., Newcomb, J., et al. ( 2004) Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35, 2390–2395.
Lindvall, O. and Kokaia, Z. (2004) Recovery and rehabilitation in stroke: stem cells. Stroke 35, 2691–2694.
Newman, M. B., Misiuta, I., Willing, A. E., et al. ( 2005) Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Rev. 14, 29–43.
Lichtenberg, F. (2002) Benefits and costs of newer drugs: an update. Natl. Bureau Economic Res. 8996.
Cowper, P. A. (2004) Economic effects of beta-blocker therapy in patients with heart failure. Am. J. Med. 116, 104–111.
MedMarkets. MedMarket diligence, April 2005, vol. 4.
Mason, J., Freemantle, N., Nazareth, I., et al. ( 2001) When is it cost-effective to change the behavior of health professionals? JAMA 286, 2988–2992.
Available at: http://www.seniorjournal.com/NEWS/Alzheimers/04-27-01 AlzCostSoar.htm. December 2005.
World Health Organization. Cardiovascular Disease Program, Geneva, Switzerland. http://www.who.int/cardiovascular_diseases/en.
Vilas-Boas, F., Feitosa, G. S., Soares, M. B. P., et al. ( 2004) Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas cardiomyopathy. A case report. Arquivos Brasileiros de Cardiologia 82, 185–187.
Soares, M. B., Lima, R. S., Rocha, L. L., et al. (2004) Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am. J. Pathol. 164, 441–447.
ExtraGraft. http://www.silvestrelabs.com.br. December 2005.
Simon, P. and Hoerstrup, M. D. (2002) Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106, 1–143.
Ahsan, T. and Nerem, R. M. (2005) Bioengineered tissues: the science, the technology, and the industry. Orthod. Craniofacial Res. 8, 134–140.
Broxmeyer, H. E., Douglas, G. W., Hangoc, G., et al. ( 1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86, 3828–3832.
Jones, C. A. (1999) Umbilical cord blood transplantation. Arch Dis. Child. 81, 282.
Knudtzon, S. (1974) In vitro growth of granulocyte colonies from circulating cells in human cord blood. Blood 43, 357–361.
McGuckin, C. P., Forraz, N., Baradez, M. O., et al. ( 2005) Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 38, 245–255.
Sanberg, P. R., Willing, A. E., Garbuzova-Davis, S., et al. ( 2005) Umbilical cord blood-derived stem cells and brain repair. Ann. NY Acad. Sci. 1049, 67–83.
American Health Assistance Foundation. Available at: http://www.ahaf.org. December 2005.
Orsini, L. S., Castelli-Haley, J., Kennedy, S., and Huse, D. M. (2004) Healthcare utilization and expenditures among privately insured patients with Parkinson’s disease in the United States. Presented at the 8th International Congress of Parkinson’s Disease and Movement Disorders, Rome, Italy, June 14-17, 2004. Published in Mov. Disord. 19(Suppl 9), 145–146.
Johnson, S. (2005) The brain business: niche field of neurotechnology holds out great promise, but firms seeking to develop treatments take big risks. Mercury News, July 11, 2005, E1.
IASP International Association of Science Parks, December 2005. Available at:http://www.iasp.ws.
European Group on Ethics in Science and New Technologies. December 2005. Available at: http://europa.eu.int.
Mandel, M. Business Week, December 2005. Available at: http://www.businessweek.com/the_thread/economicsunbound.
American Heart association. Available at: http://www.strokecenter.org/prof/awards.htm.
Baker, L. and Deal, B. Some economic Implications of State Stem Cell Funding Programs. Available at: http://region.princeton.edu/media/pub/pub_main_10.pdf.
Javitt and Chiang, eds. (1995) Economic impact of diabetes. In Diabetes in America.
Orkin, S. H. and Morrison, S. J. (2002) Biomedicine: Stem-cell competition. Nature 418, 25–27.
Scandal for Cloning Embryos: A Tragic Turn for Science. Available at: http://www.nytimes.com/2005/12/16/science.
Stewart, S., Pearson, S., and Horowitz, J. D. (1998) Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch. Intern. Med. 158, 1067–1072.
Orlic, D., Kajstura, J., Chimenti, S., et al. ( 2001) Bone marrow cells regenerate infarcted myocardium. Nature 410, 701–705.
Verfaillie, C. M. (2000) Stem cell plasticity. Graft 3, 296–298.
Gallacher, L., Murdoch, B., Wu, D. M., et al. ( 2000) Isolation and characterization of human CD34-Lin- and CD34+Lin- hematopoietic stem cells using cell surface markers AC 133 and CD7. Blood 95, 2813–2820.
Lei, M., Podell, E. R., Baumann, P., and Cech, T. R. (2003) DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA. Nature 426, 198.
U. S. Food and Drug Administration Department of Health and Human Services. Last updated: October 21, 2005.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Cruz, L.E., Azevedo, S.P. (2006). Stem Cells and Regenerative Medicine. In: Sanberg, C.D., Sanberg, P.R. (eds) Cell Therapy, Stem Cells, and Brain Repair. Contemporary Neuroscience. Humana Press. https://doi.org/10.1007/978-1-59745-147-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-59745-147-5_14
Publisher Name: Humana Press
Print ISBN: 978-1-58829-502-6
Online ISBN: 978-1-59745-147-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)